Honasa Consumer: Intimation regarding proposed Scheme of Amalgamation between wholly owned subsidiaryand step-down wholly…
Honasa Consumer (HONASA) filed a disclosure titled "Intimation regarding proposed Scheme of Amalgamation between wholly owned subsidiaryand step-down wholly owned subsidiary of Honasa Consumer Limited". The company is valued at about ₹14,707 crore.
What happened
Honasa Consumer (HONASA) filed a disclosure with the exchanges on 28 October 2026 at 06:22 PM titled "Intimation regarding proposed Scheme of Amalgamation between wholly owned subsidiaryand step-down wholly owned subsidiary of Honasa Consumer Limited".
Company snapshot
Honasa Consumer is a small-cap company in the Fast Moving Consumer Goods sector, with a market value of about ₹14,707 crore.
The stock last traded at ₹451.1, against a 52-week range of ₹248.4–₹509.8 (11.5% below the high).
Before this filing the shares had moved −8.5% over the month and −1.1% over three months. Average daily turnover over the last 20 sessions was about ₹141 crore.
Promoters held 35.47% at the end of Q1 FY27, down 0.07% points from the previous quarter; 4.15% of promoter shares were pledged. Foreign institutions owned 13.64% and domestic institutions 21.58%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 595 | 41.3 | 1.27 |
| Q2 FY26 | 1,133 | 80.6 | 2.47 |
| Q3 FY26 | 602 | 50.2 | 1.54 |
| Q4 FY26 | 657 | 69.2 | 2.13 |
| Q1 FY27 | 756 | 90.2 | 2.77 |
What history shows
This is not the company's first m&a disclosure: BCEIE has 3 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 0.4% on average the next trading day and was up 6.3% on average after five days (3 filings with price data).
Across 82 similar disclosures by other Fast Moving Consumer Goods companies, shares moved +0.5% on average the next day and +0.3% over five days; 48% of them rose the next day.
Market-wide, 2,167 m&a filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 25 Aug 2026 | Update On Proposed Acquisition Of Fluence Pharma Private Limited | −0.1% | −3.2% |
| 23 Jun 2026 | M&A | −0.5% | +11.1% |
| 23 Jun 2026 | M&A | −0.5% | +11.1% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
- 6 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Honasa Consumer elevates Vipul Maheshwari to CPTO amid AI push
- Honasa Consumer elevates Vipul Maheshwari to chief product and technology officer
- Honasa Consumer Elevates Vipul Maheshwari to CPTO, Strengthens Focus on AI-Led Transformation
- Honasa Consumer elevates Vipul Maheshwari to chief product & technology officer
- Honasa Consumer Promotes Vipul Maheshwari To Chief Product & Technology Officer
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.